T-Rex 2X Long MSTR Daily Target ETF vs Vaxcyte Inc. Common Stock — how do they compare? T-Rex 2X Long MSTR Daily Target ETF trades at $32.75 (market cap $790.58M), while Vaxcyte Inc. Common Stock trades at $67.37 (market cap $10.51B). The key difference: Vaxcyte Inc. Common Stock is far larger — about 13.3× T-Rex 2X Long MSTR Daily Target ETF's market cap, and Vaxcyte Inc. Common Stock is trading nearer its 52-week high, T-Rex 2X Long MSTR Daily Target ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold T-Rex 2X Long MSTR Daily Target ETF for 19 Days and Vaxcyte Inc. Common Stock for 0 Days on average.
| MSTU | PCVX | |
|---|---|---|
Market Cap | $790.58M | $10.51B |
Volume | 1,852,380 | 2,644,694 |
Sector | Leveraged / Inverse | Health |
52-Week High | $389.00 | $73.82 |
52-Week Low | $14.60 | $40.32 |
Typical Hold Time | 19 Days | 0 Days |
Enterprise Value | — | $9.14B |
Signals from Pluang's Aura AI — not financial advice
MSTU trades at $38.54, down 0.57% with a bearish technical signal. The stock faces resistance at $40-$45 while finding support at $37-$33 levels. Recent corporate actions include a 10:1 reverse stock split effective August 24, 2026, and a $0.29 dividend declaration. Trading activity remains elevated as investors seek leveraged exposure to the underlying company amid market volatility.
The outlook remains cautious with technical indicators showing bearish momentum and limited fundamental data available. Key risks include the leveraged ETF structure's daily compounding effects and dependence on underlying stock performance. Investors should monitor for updated financial disclosures and analyst coverage to assess the fund's positioning and valuation metrics.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
MSTU is a leveraged ETF that seeks daily investment results corresponding to 200% of the daily performance of the MicroStrategy Incorporated (MSTR) stock. It is designed as a tactical tool for experienced traders to take a bullish (long) position in MSTR, a company known for its significant Bitcoin holdings. Due to the effects of compounding and leverage, the ETF is intended to be held for a single day and is not suitable for long-term investment.
Read more on MSTU →Vaxcyte, Inc. is a clinical-stage vaccine company that engineers protein-based vaccines to prevent bacterial diseases such as invasive pneumococcal disease, using its proprietary cell-free protein synthesis platform to develop candidates including the pneumococcal conjugate vaccines VAX-31 and VAX-24.
Read more on PCVX →